EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Route of Allergen Immunotherapy: A Global Look Into Physicians' Motivations

Carmen Vidal iD, Davide P Caimmi iD, Pablo Rodriguez Del Rio iD, Óscar Lado-Baleato iD, Francisco Gude iD, Pilar Rico-Nieto iD, Thomas B Casale iD, Jorge A Aguilar iD, Maryam Ali Al-Nesf iD, Fatima Ashkanani iD, Adeeb Bulkhi iD, Juan C Cardet iD und 31 weitere

Allergy · 06.07.2026

DOI: 10.1111/all.70439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, online erschienen am 06.07.2026. Verfasst von Carmen Vidal und 42 weiteren Autor:innen. Beteiligte Einrichtung: Allergy Service, Complejo Hospitalario Universitario de Santiago. Faculty of Medicine, Universidade de Santiago de Compostela, Santiago de Compostela…. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: ALK-Abelló A/S Pharmaceutical Company, Stallergenes-Greer Pharmaceutical Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Current Allergen Immunotherapy (AIT) guidelines provide no definitive guidance on route selection, whether subcutaneous (SCIT) or sublingual (SLIT). The primary objective of this study was to characterize real‐world AIT prescription patterns, with emphasis on route selection, using a factor analysis approach in a large international cohort.

Methods

The CHOICE study is a real‐life, multicentre, international, observational, cross‐sectional web‐based survey conducted across 20 countries between November 2019 and April 2024. Participating doctors completed standardized questionnaires for each consecutive AIT prescription. Thirteen patient‐related and product‐related parameters were analyzed using exploratory and confirmatory factor analysis. Latent factors identified were subsequently incorporated into multivariate mixed logistic regression models with country and physician nested within country as random intercepts.

Results

Data from 467 physicians and 11550 patients were analyzed; 60.0% of prescriptions were SCIT and 40.0% were SLIT. Three latent factors were identified: (F1) Scientific and clinical evidence‐Based; (F2) Resource and access optimisation; and (F3) Tailored for the patient and their lifestyle. When country was modeled as a random intercept, all three factors were significantly associated with SLIT prescription. After adjustment for both country and physician, F2 was associated with reduced probability of SLIT prescription (OR 0.42; 95% CI 0.31, 0.59), while F3 was strongly associated with an increased probability of SLIT prescription (OR 10.90; 95% CI 7.20, 16.57). Variability attributable to country (ICC 0.86) and physician (ICC 0.74) was high.

Conclusions

Patient‐centred considerations increase the likelihood of SLIT use while considering the cost of the treatment increases the likelihood of SCIT use. Substantial variability in AIT route selection is attributable to country‐ and physician‐level factors.

Schlagwörter

Stichwörter der Autor:innen

SCIT (subcutaneous immunotherapy)SLIT (sublingual immunotherapy)allergen immunotherapyasthmafactor analysispreferencesrhinitis

Autor:innen und Institutionen

  • Allergy Service, Complejo Hospitalario Universitario de Santiago. Faculty of Medicine, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
  • IDESP, UMR 1318 Univ. Montpellier-INSERM-Premedical Inria and Allergy Unit, University Hospital of Montpellier, Montpellier, France.
  • Allergy Department, Pediatric Universitary Hospital Universitario Niño Jesus.IIS-Princesa. RICORS Center RD24/0007/0037. Fundación Hospital Niño Jesus (FIBHNJS), Madrid, Spain.
  • Research Methods Group (RESMET), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
  • Concepción Arenal Primary Care Center, Faculty of Medicine, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
  • School of Medicine, University CEU San Pablo, Madrid, Spain.

ORCID-Profile: Carmen Vidal, Davide P Caimmi, Pablo Rodriguez Del Rio, Óscar Lado-Baleato, Francisco Gude, Pilar Rico-Nieto, Thomas B Casale, Jorge A Aguilar, Maryam Ali Al-Nesf, Fatima Ashkanani, Adeeb Bulkhi, Juan C Cardet, Claudia Almendarez, Silvia Caimmi, Iván Cherrez, Enza D'Auria, Stephanie Dramburg, Motohiro Ebisawa, Naoko Fusayasu, Maximiliano Gomez, Carla Irani, Connie Katelaris, Narinder Kaur, Oksana KurBacheva, Désirée Larenas-Linnemann, Margaret Li, Olga Patricia Monge-Ortega, Pablo Moreno, Oliver Pfaar, Cesar F Pozo-Beltrán, Marta E Rubio, Jorge Sanchez, Giovanni Sedo, Silvia Uriarte, Lin Yang, Hao Chen, Rongfei Zhu, Pascal Demoly

Förderung

  • ALK-Abelló A/S Pharmaceutical Company
  • Stallergenes-Greer Pharmaceutical Company

Zitieren

APA

Vidal, C., Caimmi, D. P., Rodriguez Del Rio, P., Lado-Baleato, Ó., Gude, F., Rico-Nieto, P., Casale, T. B., Aguilar, J. A., Al-Nesf, M. A., Ashkanani, F., Bulkhi, A., Cardet, J. C., Almendarez, C., Caimmi, S., Cherrez, I., D'Auria, E., Dramburg, S., Ebisawa, M., Fusayasu, N., …, & CHOICE‐Global Survey Team (2026). Route of Allergen Immunotherapy: A Global Look Into Physicians' Motivations. Allergy. https://doi.org/10.1111/all.70439

Vancouver

Vidal C, Caimmi DP, Rodriguez Del Rio P, Lado-Baleato Ó, Gude F, Rico-Nieto P, et al. Route of Allergen Immunotherapy: A Global Look Into Physicians' Motivations. Allergy. 2026. doi:10.1111/all.70439

BibTeX
@article{Vidal2026,
  author = {Vidal, Carmen and Caimmi, Davide P and Rodriguez Del Rio, Pablo and Lado-Baleato, Óscar and Gude, Francisco and Rico-Nieto, Pilar and Casale, Thomas B and Aguilar, Jorge A and Al-Nesf, Maryam Ali and Ashkanani, Fatima and Bulkhi, Adeeb and Cardet, Juan C and Almendarez, Claudia and Caimmi, Silvia and Cherrez, Iván and D'Auria, Enza and Dramburg, Stephanie and Ebisawa, Motohiro and Fusayasu, Naoko and Gomez, Maximiliano and Gonzalez-Diaz, Sandra and Irani, Carla and Kamaev, Andrey and Katelaris, Connie and Kaur, Narinder and KurBacheva, Oksana and Larco, José I and Larenas-Linnemann, Désirée and Li, Margaret and Monge-Ortega, Olga Patricia and Moreno, Pablo and Pfaar, Oliver and Pozo-Beltrán, Cesar F and Rubio, Marta E and Sanchez, Jorge and Sedo, Giovanni and Uriarte, Silvia and Yang, Lin and Chen, Hao and Zhu, Rongfei and Demoly, Pascal and Calderon, Moises A and CHOICE‐Global Survey Team, CHOICE‐Global Survey Team},
  title = {Route of Allergen Immunotherapy: A Global Look Into Physicians' Motivations},
  journal = {Allergy},
  year = {2026},
  doi = {10.1111/all.70439}
}
Kostenlos starten →